We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA PANEL VOTES DOWN EXPANDED INDICATIONS FOR NOVACOR LVAS
FDA PANEL VOTES DOWN EXPANDED INDICATIONS FOR NOVACOR LVAS
June 11, 2004
The FDA’s Circulatory System Devices Panel voted June 8 to not recommend approval of expanded indications for World Heart’s Novacor left ventricular assist device (LVAS).